1ZM7 image
Deposition Date 2005-05-10
Release Date 2005-05-17
Last Version Date 2023-08-23
Entry Detail
PDB ID:
1ZM7
Keywords:
Title:
Crystal structure of D. melanogaster deoxyribonucleoside kinase mutant N64D in complex with dTTP
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.23
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Deoxynucleoside kinase
Gene (Uniprot):dnk
Mutations:N64D
Chain IDs:A, B, C, D
Chain Length:230
Number of Molecules:4
Biological Source:Drosophila melanogaster
Primary Citation
Structural basis for the changed substrate specificity of Drosophila melanogaster deoxyribonucleoside kinase mutant N64D.
Febs J. 272 3733 3742 (2005)
PMID: 16008571 DOI: 10.1111/j.1742-4658.2005.04803.x

Abstact

The Drosophila melanogaster deoxyribonucleoside kinase (Dm-dNK) double mutant N45D/N64D was identified during a previous directed evolution study. This mutant enzyme had a decreased activity towards the natural substrates and decreased feedback inhibition with dTTP, whereas the activity with 3'-modified nucleoside analogs like 3'-azidothymidine (AZT) was nearly unchanged. Here, we identify the mutation N64D as being responsible for these changes. Furthermore, we crystallized the mutant enzyme in the presence of one of its substrates, thymidine, and the feedback inhibitor, dTTP. The introduction of the charged Asp residue appears to destabilize the LID region (residues 167-176) of the enzyme by electrostatic repulsion and no hydrogen bond to the 3'-OH is made in the substrate complex by Glu172 of the LID region. This provides a binding space for more bulky 3'-substituents like the azido group in AZT but influences negatively the interactions between Dm-dNK, substrates and feedback inhibitors based on deoxyribose. The detailed picture of the structure-function relationship provides an improved background for future development of novel mutant suicide genes for Dm-dNK-mediated gene therapy.

Legend

Protein

Chemical

Disease

Primary Citation of related structures